Mode
Text Size
Log in / Sign up
N/A N=15 Treatment

An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake

Dry Eye Syndromes

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Investigators' Evaluation of the Tear Lake; Comparison of Baseline Result to 7 Days — 129 mean percent change from baseline

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
NDE L68 StableFit® Punctal Plug (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Mati Therapeutics Inc.
Primary completion
Dec 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Investigators' Evaluation of the Tear Lake; Comparison of Baseline Result to 7 Days
129
PRIMARY
Investigators' Evaluation of the Tear Lake; Comparison of Baseline Result to 28 Days
143
SECONDARY
Investigator's Evaluation of the Subject's Acceptance of the NDE L68 StableFit® Punctal Plug, Comparison of Baseline Result to 28 Days

Summary

To evaluate the effect of the NDE L68 StableFit® punctal plug on the tear lake.

Eligibility Criteria

Inclusion Criteria

  • A male or female subject, 18 years of age or older, in good general health at the time of the baseline examination, who may or may not have a mild to moderate dry eye condition
  • A subject must be able to read, comprehend and be willing to give HIPAA authorization and informed consent
  • A subject must be willing to have a punctal plug inserted in the lower punctum of one of their eyes
  • A subject must be willing to comply with all study instructions, agree to make all office appointments, and complete the entire course of the study

Exclusion Criteria

  • A subject with a history of complications, adverse events, trauma or disease in the nasolacrimal area, whether or not it was due to punctal plug wear, including but not limited to dacryocystitis, inflammation or canaliculitis in the planned study eye
  • A subject with a history of intolerance to punctal plugs
  • A subject with structural lid abnormalities (e.g., ectropion, entropion) in the planned study eye
  • A subject with any clinically significant lid, conjunctival or corneal findings in the planned study eye at the baseline visit
  • A subject with a severe dry eye condition
  • A subject experiencing epiphora in the planned study eye
  • A subject experiencing any clinically significant ocular pain or discomfort in or around either eye at the baseline visit
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04280653). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search